Disrupted Brain Network in Progressive Mild Cognitive Impairment Measured by Eigenvector Centrality Mapping is Linked to Cognition and Cerebrospinal Fluid Biomarkers.

Mild cognitive impairment (MCI) is a heterogeneous condition associated with a high risk of progressing to Alzheimer's disease (AD). Although functional brain network alterations have been observed in progressive MCI (pMCI), the underlying pathological mechanisms of network alterations remain unclear. In the present study, we evaluated neuropsychological, imaging, and cerebrospinal fluid (CSF) data at baseline across a cohort of: 21 pMCI patients, 33 stable MCI (sMCI) patients, and 29 normal controls. Fast eigenvector centrality mapping (fECM) based on resting-state functional MRI (rsfMRI) was used to investigate brain network organization differences among these groups, and we further assessed its relation to cognition and AD-related pathology. Our results demonstrated that pMCI had decreased eigenvector centrality (EC) in left temporal pole and parahippocampal gyrus, and increased EC in left middle frontal gyrus compared to sMCI. In addition, compared to normal controls, patients with pMCI showed decreased EC in right hippocampus and bilateral parahippocampal gyrus, and sMCI had decreased EC in right middle frontal gyrus and superior parietal lobule. Correlation analysis showed that EC in the left temporal pole was related to Wechsler Memory Scale-Revised Logical Memory (WMS-LM) delay score (r = 0.467, p = 0.044) and total tau (t-tau) level in CSF (r = -0.509, p = 0.026) in pMCI. Our findings implicate EC changes of different brain network nodes in the prognosis of pMCI and sMCI. Importantly, the association between decreased EC of brain network node and pathological changes may provide a deeper understanding of the underlying pathophysiology of pMCI.

[1]  Frederik Barkhof,et al.  Brain network alterations in Alzheimer's disease measured by Eigenvector centrality in fMRI are related to cognition and CSF biomarkers , 2014, Human brain mapping.

[2]  P. Coupé,et al.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression , 2015, Neurobiology of Aging.

[3]  Frithjof Kruggel,et al.  In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease , 2013, The Journal of comparative neurology.

[4]  Wei Xu,et al.  Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Zhijun Zhang,et al.  Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment , 2012, NeuroImage.

[6]  Eric Westman,et al.  Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD , 2013, Scientific Reports.

[7]  L. McEvoy,et al.  Predicting MCI outcome with clinically available MRI and CSF biomarkers , 2011, Neurology.

[8]  Clare E. Mackay,et al.  The effects of APOE on the functional architecture of the resting brain , 2012, NeuroImage.

[9]  A. Mitchell,et al.  Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.

[10]  Davide Quaranta,et al.  Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[11]  Yang Yu,et al.  Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease , 2015, Neural plasticity.

[12]  Maxime Guye,et al.  Basal functional connectivity within the anterior temporal network is associated with performance on declarative memory tasks , 2011, NeuroImage.

[13]  Thomas van Bruggen,et al.  Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion? , 2012, Psychiatry Research: Neuroimaging.

[14]  Roxana Alexandridis,et al.  Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease. , 2016, JAMA neurology.

[15]  R. Versace,et al.  The disconnection syndrome in the Alzheimer’s disease: The cross-modal priming example , 2013, Cortex.

[16]  David Eidelberg,et al.  Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT , 2007, Neurobiology of Aging.

[17]  M. Saling,et al.  Differential Functional Connectivity Correlates of Cerebrospinal Fluid Biomarkers in Dementia of the Alzheimer's Type , 2015, Neurodegenerative Diseases.

[18]  Bradford C. Dickerson,et al.  Fractionating verbal episodic memory in Alzheimer's disease , 2011, NeuroImage.

[19]  G. V. Van Hoesen,et al.  Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. , 1994, Archives of neurology.

[20]  H. Levine,et al.  Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis , 2016, The Journal of Neuroscience.

[21]  M. Viitanen,et al.  PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment , 2007, Neurology.

[22]  Hiroshi Matsuda,et al.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.

[23]  Claus Zimmer,et al.  Selectively and progressively disrupted structural connectivity of functional brain networks in Alzheimer's disease — Revealed by a novel framework to analyze edge distributions of networks detecting disruptions with strong statistical evidence , 2013, NeuroImage.

[24]  Michael I. Miller,et al.  Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease , 2012, Alzheimer's & Dementia.

[25]  V. Calhoun,et al.  Default mode network connectivity in stable vs progressive mild cognitive impairment , 2011, Neurology.

[26]  Nick C Fox,et al.  Conversion of amyloid positive and negative MCI to AD over 3 years , 2009, Neurology.

[27]  H. Engler,et al.  PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.

[28]  James T. Becker,et al.  A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity , 2015, NeuroImage: Clinical.

[29]  J. Molinuevo,et al.  Cortical Brain Metabolism as Measured by Proton Spectroscopy Is Related to Memory Performance in Patients with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[30]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[31]  Maja A. A. Binnewijzend,et al.  Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment , 2012, Neurobiology of Aging.

[32]  G. Chételat,et al.  Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment , 2015, NeuroImage: Clinical.

[33]  D. Salmon,et al.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. , 2014, Journal of Alzheimer's disease : JAD.

[34]  A. Fagan,et al.  Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. , 2013, JAMA neurology.

[35]  A. Salehi,et al.  Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy. , 2011, Journal of Alzheimer's disease : JAD.

[36]  Byeong-Chae Kim,et al.  Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease , 2012, Psychiatry Research: Neuroimaging.

[37]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[38]  K. Oguz,et al.  Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease. , 2016, Archives of gerontology and geriatrics.

[39]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[40]  M. Albert,et al.  MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD , 2008, Neurology.

[41]  J. Jolles,et al.  Ten-year risk of dementia in subjects with mild cognitive impairment , 2006, Neurology.

[42]  Helge Malmgren,et al.  A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. , 2013, Journal of Alzheimer's disease : JAD.

[43]  A. Poremba,et al.  Local field potential correlates of auditory working memory in primate dorsal temporal pole , 2016, Brain Research.

[44]  R. Turner,et al.  Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain , 2010, PloS one.

[45]  H. Arai,et al.  Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease , 2009, Journal of the Neurological Sciences.

[46]  N. Cera,et al.  Characterization of resting state activity in MCI individuals , 2013, PeerJ.

[47]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[48]  Frederik Barkhof,et al.  Fast Eigenvector Centrality Mapping of Voxel-Wise Connectivity in Functional Magnetic Resonance Imaging: Implementation, Validation, and Interpretation , 2012, Brain Connect..

[49]  Min Xuan,et al.  Altered brain network centrality in depressed Parkinson's disease patients , 2015, Movement disorders : official journal of the Movement Disorder Society.

[50]  Kingshuk Roy Choudhury,et al.  Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. , 2013, Radiology.

[51]  Jessica A. Turner,et al.  Behavioral Interpretations of Intrinsic Connectivity Networks , 2011, Journal of Cognitive Neuroscience.

[52]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.